Established by Dr. Bruce N. Cronstein in July 2000, the Division of Translational Medicine is one of the newest divisions within the Department of Medicine and one of the newest and most active clinical pharmacology divisions in the New York region.

The mission of the Division of Translational Medicine is research-centered and is focused on four primary goals:

  • to understand the action and metabolism of drugs currently in use
  • to help translate laboratory discoveries into agents for use in clinical care
  • to understand the genetic and metabolic bases for responses to and toxicity of pharmacologically active agents
  • to understand and influence those factors that govern the patient's capacity and willingness to comply with pharmacologic regimens
  • to study the effects of drugs upon human diseases as a means to investigate the underlying pathogenic mechanisms

The members of the division carry out pharmacological investigations in three laboratories and have a broad range of research and clinical interests.